Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 23 for “"ACTIVATION OF ONCOGENES"”.
-
Mutations on secondary DNA structures leading to the cancer-driving activation of oncogenes
… spinal cord tumours represent the leading cause of disease-related death in children. Considering the low mutational burden for most cases, studying driver mutations is important and may reveal promising targets for therapy. Mutations on DNA secondary structures could have a mechanistic link to …
-
Development of a CENH3-based and non-viral vector system
… main reason is the very efficient administration of the vector into the target cells. The viral background of these systems also has severe side effects like e.g. immunological reactions of the patient or the activation of oncogenes due to insertional mutagenesis, which can result in cancer …
-
UNRAVELLING THE MOLECULAR MECHANISMS UNDERLYING ONCOGENE¿INDUCED DNA DAMAGE
Activation of oncogenes in normal cells induces DNA damage accumulation and evokes a DNA damage response (DDR) that has been proposed to behave as a barrier against malignant transformation by inducing either apoptosis or cellular senescence, and therefore avoiding the clonal propagation of the …
-
Abrogation of B-RafV600E induced senescence by AKT activation via FoxM1 expression in primary human hepatocytes
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. Hepatocarcinogenesis is a stepwise process and multiple genes alteration are involved such as activation of oncogenes, inactivation of tumor suppressor genes, activation of growth factor and their cognitive …
-
Investigation of the Role of Senescent Tumor Cells in Colorectal Cancer Liver Metastasis
… to non-proliferating tumor cells. Various kinds of stress such as hypoxia, reactive oxygen species, frequent replication, and activation of oncogenes can induce senescence in tumor cells. For such reason that senescent tumor cells lack the ability to proliferate, their significance have been …
-
Γενετικές και μοριακές αλλοιώσεις του γονιδίου BRCA1 στον καρκίνο του μαστού
… IS A MULTISTAGE PROCESS IN WHICH THE ACTIVATION OF ONCOGENES ANDTHE INACTIVATION OF TUMOUR SUPPRESSOR GENES (TSGS) ARE REQUIRED FOR THE DEVELOPMENT OF THE DISEASE. RECENT EVIDENCE ALSO INDICATES A THIRD GROUP OF GENES IN CARCINOGENESIS, INVOLVED IN DNA REPAIR. THE AIM OF THE PRESENT …
-
The role of PARPs and APLF in DNA interstrand crosslink repair
<p>Over the duration of every organism’s life its cells continuously face insults to their DNA. The accumulation of lesions results in cell death, inflammation and, following the activation of oncogenes or inactivating mutations of DNA repair factors, cancer formation. One particularly deleterious …
-
In silico και in vivo ανάλυση της αντιγραφής και επιδιόρθωσης του DNA
… eukaryotes, replication initiates from hundreds of sites scattered across the genome called origins of replication. This process takes place during S phase of the cell cycle and is tightly regulated in both time and space in order to ensure precise duplication of the entire genome within this …
-
Επίδραση της ιοντίζουσας ακτινοβολίας στην έκφραση τελομεράσης στον καρκίνο του μαστού
The aim of this work was to study the effect of ionizing radiation on cell viability and on telomerase expression. The regulatory mechanisms of human telomerase reverse transcriptase (hTERT) expression as well as telomerase activity were investigated in relation with breast cancer cells features. …
-
Role of novel tumor suppressors in colon cancer : Mechanisms and therapeutic opportunities
… in the world and the fourth most common cause of cancer related deaths. Inflammation is one of the risk factors for development of colon cancer. Interestingly immune cells as mast cells and inflammatory mediators as LTC4 play an important role in colon cancer. Genetic predisposition, which …
-
Novel Inhibitors of the Epigenetic Reader Proteins MBD2 and UHRF1
DNA hypermethylation can trigger silencing of tumor suppressor genes during cancer development and progression, partly through binding by methylated-DNA binding proteins (MBD), such as MBD2, that function as “epigenetic readers” and recruit co- repressor complexes to promote gene repression. …
-
Conditional inactivation of the BRCA1 tumour suppressor gene in the mouse ovarian surface epithelium in vitro and in vivo
… gene result in a significantly increased risk of developing EOC and a large proportion of sporadic EOCs display some sort of BRCA1 dysfunction. Using mice with conditional expression of Brca1, we inactivated Brca1 in the murine OSE and demonstrate that this inactivation results in the …
-
Ταυτοποίηση προγνωστικών δεικτών επιθετικής βιολογικής συμπεριφοράς στον καρκίνο του κόλου
PURPOSE AND METHODS Modern perception of carcinogenesis and tumor biology enlists genes-proteins that canact as oncogenes or tumor suppressive factors. Tumor initiation requires –according to theaforementioned- the constant activation of oncogenes together with silencing of the tumorsuppressors.We …
-
Prognostic Implications of Cellular Senescence in Acute Myeloid Leukemia
… for which biologically grounded predictors of outcome remain a clinical need. In addition to tumor cell death, antineoplastic drugs can mediate a long-lasting growth arrest of vital, metabolically active tumor cells termed therapy-induced senescence, but structured investigations into its …
-
Identifying Protein Kinase Tbk1 As A Novel Inhibitor of Intestinal Tumorigenesis
… progresses in order to improve the strategies of CRC prevention and therapy. A major factor that drives the development of CRC is genetic mutations that lead to activation of oncogenes and inactivation of tumor suppressor genes in intestinal epithelial cells (IECs). In addition, the initiation …
-
Interactions between the IGF system and cholesterol metabolism in breast cancer
… obesity are associated with an increased risk of breast cancer. Several obesity-related host factors involved in systemic metabolism can influence tumor initiation, progression, and/or response to therapy.<br/>Insulin like growth factor (IGF) signalling and levels of cholesterol, particularly …
-
Μελέτη έκφρασης πρωτεϊνικών προϊόντων σε επίμυες των γονιδίων EGFR & ERBB3 που σχετίζονται με καρκινογένεση στη στοματική κοιλότητα
… Cancers that develop in the oral cavity are often not detected until the later stages of the disease when treatment options are limited. The major causative factors causing OSCC is tobacco and alcohol consumption. Oral carcinogenesis is a multistep process in which genetic events lead to …
-
Μελέτη του μηχανισμού συμβολής του ογκοκατασταλτικού γονιδίου ATM στην ογκογένεση στο στόμα
… sixth most common malignancy and a major cause of morbidity and mortality by cancer worldwide. Despite the advances in treatment, including surgery, chemotherapy and radiotherapy, there has not been any important improvement in the prognosis over the last four decades. The most important …
-
AVIAN LEUKOSIS VIRUS DNA INTEGRATION: REGULATION AND SELECTION IN TUMORIGENESIS
A key requirement of the retroviral lifecycle is integration of the proviral genome into the host cell genome. This makes retroviral vectors uniquely suited for gene therapy applications. While murine leukemia virus (MLV) and human immunodeficiency virus-1 (HIV-1) based vectors are commonly used, …
-
Impact of Ionizing Radiation on the Energy Metabolism of Normal and Tumor Cells in the Brain
Radiotherapy (RT) is one of the most common and effective cancer treatments, with approximately half of all cancer patients undergoing this form of therapy. Over recent decades, advancements in both technology and radiobiology have significantly transformed the field of radiation oncology. …
Page 1 of 2